122例哮喘患者舒张试验结果分析

doi:10.6040/j.issn.1671-7554.0.2019.1435

摘要/Abstract

摘要： 目的分析哮喘患者肺功能和支气管舒张试验结果及特点,探讨肺功能检查对哮喘诊断、疗效判断的价值。方法收集2018年入住山东大学第二医院呼吸内科、确诊为哮喘患者的肺功能检查资料,共计122例,根据FEV1/FVC%分为肺功能正常组(30例)及气流受限组(92例),其中气流受限组根据一秒量FEV1分为3个亚组(轻度组63例、中重度组16例、重度组13例),分析各组肺功能及舒张试验数据。结果正常组、轻度组、中重度组、重度组支气管舒张试验阳性率分别为16.7%、58.7%、81.3%、100.0%,组间差异有统计学意义(χ2=35.8, P=0.001);在正常组,FEV1和FVC的改善量、改善率差异无统计学意义(P=0.39, P=0.14);在气流受限组,中重度组及重度组一秒率试验前、试验后数值低于轻度组,差异有统计学意义(试验前:χ2=52.16, P<0.001;试验后:χ2=49.49, P<0.001);各组的试验后一秒率均较试验前升高,差异有统计学意义(P均<0.05);舒张试验后,解除气流受限者仅占9.8%,且均为轻度组。结论哮喘患者支气管舒张试验结果提示,随阻塞程度加重,呈现阳性率渐增趋势。肺功能正常也可行舒张试验,阳性病例呈特殊流速-容量环表现。哮喘治疗与控制是终生的、个体化的,定期复查肺功能,有助于指导临床治疗及全程哮喘管理。

关键词: 肺功能测定, 支气管舒张试验, 哮喘, 一秒量, 一秒率

Abstract: Objective To analyze the results and characteristics of pulmonary function test and bronchodilator test in patients with asthma, and to explore the value of pulmonary function test in diagnosis and curative effect of asthma. Methods Pulmonary function results of 122 patients with asthma in 2018 were collected. According to FEV1/FVC%, the cases were divided into normal group(n=30)and airflow restricted group(n=92). Airflow restricted group was further divided into mild group(n=63), moderately severe group(n=16)and severe group(n=13)based on FEV1. Then the data of different groups were analyzed. Results The positive rates of bronchodilator test were 16.7%, 58.7%, 81.3%, and 100.0% in normal group, mild group, moderately severe group, and severe group, respectively, with a statistical difference between different groups(χ2=35.8, P=0.001). There was no significant difference of improvement quantity and improvement rate between FEV1 and FVC in normal group(P=0.39, P=0.14). FEV1/FVC% values before and after bronchodilator test in moderately severe group and severe group were lower than that in mild group(before the test: χ2=52.16, P<0.001; after the test: χ2=49.49, P<0.001). FEV1/FVC% value was increased after bronchodilator test in all airflow restricted groups(all P<0.05). Only 9.8% of patients were released from air restriction after bronchodilator test, which were entirely from mild group. Conclusion Positive rate of bronchodilator test increases depending on the aggravation of airflow obstruction in patients with asthma. The patients with normal pulmonary function can also reveive the bronchodilator test. Specific flow volume loops are showed in positive cases of normal group. It is a lifelong process and needs individualized management in the control or treatment of asthma. Pulmonary function test examined regularly is beneficial to guide clinical treatment and manage asthma.

Key words: Pulmonary function test, Bronchodilator test, Asthma, Forced expiratory volume in one second, Forced expiratory volume in one second /forced vital capacity

中图分类号:

R562.2+5

李岩,牛瑞,王超超. 122例哮喘患者舒张试验结果分析[J]. 山东大学学报 (医学版), 2020, 58(11): 81-84.

LI Yan, NIU Rui, WANG Chaochao. Analysis of the bronchodilator test of 122 patients with asthma[J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 81-84.

参考文献

[1] Boulet LP, Reddel HK, Bateman E, et al. The Global Initiative for Asthma(GINA): 25 years later[J]. Eur Respir J, 2019, 54(2): 1900598. doi: 10.1183/13993003.00598-2019.
[2] 尹硕淼,陈远彬,郑燕婵,等.不同肺功能检查方式在支气管哮喘指南中的诊断价值比较[J].中国全科医学, 2018, 21(32): 3911-3914. YIN Shuomiao, CHEN Yuanbin, ZHENG Yanchan, et al. Comparison of diagnostic value in different pulmonary function tests in the guidelines of bronchial asthma[J]. Chinese General Practice, 2018, 21(32): 3911-3914.
[3] Osborne ML, Pedula KL, O'Hollaren M, et al. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study[J]. Chest, 2007, 132(4): 1151-1161.
[4] 中国呼吸医师协会肺功能与临床呼吸生理工作委员会, 中华医学会呼吸病学分会呼吸治疗学组. 肺功能检查报告规范——肺量计检查、支气管舒张试验、支气管激发试验[J].中华医学杂志, 2019, 99(22):1681-1691.
[5] Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes[J]. Eur Respir J, 2005, 26(3): 511-522.
[6] Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry[J]. Eur Respir J, 2005, 26(2): 319-338.
[7] Becker AB, Abrams EM. Asthma guidelines: the Global Initiative for Asthma in relation to national guidelines[J]. Curr Opin Allergy Clin Immunol, 2017, 17(2): 99-103.
[8] Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests[J]. Eur Respir J, 2005, 26(5): 948-968.
[9] 陈桂芝,戚良燕,邓淑仙,等.慢性持续期支气管哮喘患者焦虑、抑郁变化趋势的研究[J].中国现代医学杂志,2015, 25(31): 40-43. CHEN Guizhi, QI Liangyan, DENG Shuxian, et al. Research on the trend of anxiety and depression of patients with asthma in chromic duration[J]. China Journal of Modern Medicine, 2015, 25(31): 40-43.
[10] 刘泽英,刘双,朱晨曦,等.支气管哮喘患者支气管舒张试验指标与疗效关系的研究[J].心肺血管病杂志, 2013, 32(5): 569-572. LIU Zeying, LIU Shuang, ZHU Chenxi, et al. Study on the relationship between the bronchial relaxation test index and the curative effects in patients with bronchial asthma[J]. Journal of Cardiovascular & Pulmonary Diseases, 2013, 32(5): 569-572.
[11] 中华医学会呼吸病学分会哮喘学组.支气管哮喘患者自我管理中国专家共识[J].中华结核和呼吸杂志, 2018, 41(3): 171-178.
[12] 邢斌,林江涛,唐华平,等.我国城区支气管哮喘急性发作住院患者治疗情况的调查分析[J].中华医学杂志, 2018, 98(8): 622-626. XING Bin, LIN Jiangtao, TANG Huaping, et al. A restrospective study of the treatment of patients hospitalized for asthma exacerbation in China[J]. National Medical Journan of China, 2018, 98(8): 622-626.
[13] 林江涛,王文巧,周新,等.我国十城市支气管哮喘控制和疾病管理及患者认知水平的变化[J].中华结核和呼吸杂志, 2018, 41(3): 191-195. LIN Jiangtao, WANG Wenqiao, ZHOU Xin, et al. Trends of asthma control, disease management and perception in China[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2018, 41(3): 191-195.
[14] Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control[J]. Eur Respir J, 2015, 46(3): 622-639.
[15] Boulet LP, FitzGerald JM, Reddel HK. The revised 2014 GINA strategy report: opportunities for change[J]. Curr Opin Pulm Med, 2015, 21(1): 1-7.
[16] 黄传君,赵方正,陈方方,等.吸入性糖皮质激素能有效控制支气管哮喘气道炎症[J].中华结核和呼吸杂志,2018,41(11): 912.
[17] 蔡绍曦,赵海金.重症哮喘的个体化治疗现状和展望[J].中华结核和呼吸杂志, 2017, 40(11): 806-808.
[18] 刘光辉.支气管哮喘的规范化诊疗[J].医学与哲学, 2015, 36(14): 22-26. LIU Guanghui. Standardized diagnosis and treatment of bronchial asthma[J]. Medicine and Philosophy, 2015, 36(14): 22-26.
[19] 王刚,张欣,王蕾,等.轻度支气管哮喘治疗策略的商榷[J].中华结核和呼吸杂志, 2018, 41(7): 572-576.
[20] 卢慧宇,徐虹,张亚明,等.雾化吸入糖皮质激素在哮喘急性发作的应用相关问题探讨[J].中华结核和呼吸杂志, 2015, 38(2): 158-160.
[21] 沈华浩,杜旭菲,应颂敏.新版中国支气管哮喘防治指南与全球支气管哮喘防治创议的异同[J].中华结核和呼吸杂志, 2018, 41(3): 166-168.
[22] 中华医学会变态反应分会呼吸过敏学组(筹),中华医学会呼吸病学分会哮喘学组.中国过敏性哮喘诊治指南[J].中华内科杂志, 2019, 58(9): 636-655.
[23] 王远征.支气管激发试验伴发晕厥1例报告[J].江西医学院学报, 2008, 48(6): 55.
[24] 张齐武,许苏丹,李虹.组胺气道激发试验致严重呼吸困难 3例[J].临床肺科杂志, 2008, 13(9): 1201.
[25] 许圣慧,关继涛,高耐芬,等.成人支气管哮喘自我管理[J].国际呼吸杂志, 2017, 37(5): 383-386. XU Shenghui, GUAN Jitao, GAO Naifen, et al. Self-management of bronchial asthma in adults[J]. International Journal of Respiration, 2017, 37(5): 383-386.

相关文章 15

[1]	刘晓菲,梁瀛,张丛溪,王娟,潘云,徐嘉蔚,常春,董亮. 92例哮喘患者血清瘦素与诱导痰嗜酸性粒细胞的关系[J]. 山东大学学报 (医学版), 2020, 1(9): 27-33.
[2]	刘清发,王超,孙启晶,宫晓丹,张才擎. IL-25通过nuocyte细胞诱导哮喘小鼠气道重塑[J]. 山东大学学报（医学版）, 2016, 54(8): 28-33.
[3]	刘琳,刘春红,王得翔,吴金香,赵继萍,刘甜,张元元,王俊飞,柳亚慧,曹柳兆,董亮. 应用呼出气一氧化氮联合脉冲振荡肺功能评估哮喘患者的小气道功能[J]. 山东大学学报（医学版）, 2016, 54(8): 78-83.
[4]	吴宏图, 丁娴, 张磊, 曹兴丽, 王峥艳, 单春明, 刘平. 儿童咳嗽变异性哮喘FeNO、hs-CRP及 IgE水平变化及意义[J]. 山东大学学报（医学版）, 2014, 52(S2): 82-83.
[5]	黄艳, 旷昕, 熊花, 刘鑫, 罗晓青, 刘斌. 柴朴汤调控VEGF、TGF-β1的表达对哮喘大鼠气道重塑的影响[J]. 山东大学学报（医学版）, 2014, 52(S1): 14-17.
[6]	李燕, 谢敏, 史小玲, 王晓燕, 唐利, 钟森, 陈庄. HSP70/CD80 DNA疫苗通过调节Th1/Th2/Treg/Th17细胞对小鼠急性哮喘的抑制作用[J]. 山东大学学报（医学版）, 2014, 52(10): 20-24.
[7]	张倩1，2，钱粉红3，周林福4，韦国桢1，柏建岭5，殷凯生4，施毅2. TLR7/8基因多态性与江苏省汉族人群哮喘发病风险及严重度的关系[J]. 山东大学学报(医学版), 2013, 51(2): 93-98.
[8]	周佳丽1,2,张岩1,王东明2,张艳2. Toll样受体4在小儿哮喘致病机制中的作用[J]. 山东大学学报(医学版), 2013, 51(06): 106-109.
[9]	吴平. 哌拉西林舒巴坦钠(4∶1)过敏致哮喘患儿心脏骤停1例[J]. 山东大学学报(医学版), 2013, 51(06): 110-110.
[10]	王得翔1，季秀丽1,2，马德东1，张玉可1，何宝龙1，王文巧1，肖伟1. 济南地区支气管哮喘患者经济负担及其影响因素分析[J]. 山东大学学报(医学版), 2012, 50(5): 124-128.
[11]	姜玉新，马玉成，李朝品. 尘螨Ⅱ类改组变应原对哮喘小鼠免疫治疗的效果[J]. 山东大学学报(医学版), 2012, 50(10): 50-.
[12]	王兆辉，姚慧 . 白细胞介素-17对哮喘小鼠嗜酸性粒细胞的影响[J]. 山东大学学报(医学版), 2011, 49(5): 58-.
[13]	张学平，王莉，龙飞，李怀臣. 黄芪多糖抑制气道平滑肌细胞α-SMA的表达[J]. 山东大学学报(医学版), 2011, 49(2): 79-.
[14]	姬峰，李艳丽，郝俊清，李鸿佳，董亮. FIZZ1诱导气道上皮间质转化导致哮喘早期气道重塑[J]. 山东大学学报(医学版), 2010, 48(2): 80-84.
[15]	迟翔宇1，李青1，王来城2，王静1. ADAM33基因F+1 位点单核苷酸多态性与支气管哮喘的相关性研究[J]. 山东大学学报(医学版), 2010, 48(10): 77-80.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed